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Ar ticle

DNAM-1 controls NK cell activation via an ITT-like motif
Zhanguang Zhang,1,2 Ning Wu,1 Yan Lu,1 Dominique Davidson,1 Marco Colonna,3
and André Veillette1,2,4
1
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Department of Medicine, McGill University, Montréal, Québec H3G 1Y6, Canada
3
Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110
4
Department of Medicine, University of Montréal, Montréal, Québec H3T 1J4, Canada

D NAM-1 (CD226) is an activating receptor expressed on natural killer (NK) cells, CD8+ T cells, and other immune cells. Upon
recognition of its ligands, CD155 and CD112, DNAM-1 promotes NK cell–mediated elimination of transformed and virus-infected cells. It also has a key role in expansion and maintenance of virus-specific memory NK cells. Herein, the mechanism by
which DNAM-1 controls NK cell–mediated cytotoxicity and cytokine production was elucidated. Cytotoxicity and cytokine
production triggered by DNAM-1 were mediated via a conserved tyrosine- and asparagine-based motif in the cytoplasmic
domain of DNAM-1. Upon phosphorylation by Src kinases, this motif enabled binding of DNAM-1 to adaptor Grb2, leading to
activation of enzymes Vav-1, phosphatidylinositol 3′ kinase, and phospholipase C-γ1. It also promoted activation of kinases
Erk and Akt, and calcium fluxes. Although, as reported, DNAM-1 promoted adhesion, this function was signal-independent
and insufficient to promote cytotoxicity. DNAM-1 signaling was also required to enhance cytotoxicity, by increasing actin
polymerization and granule polarization. We propose that DNAM-1 promotes NK cell activation via an immunoreceptor tyrosine tail (ITT)–like motif coupling DNAM-1 to Grb2 and other downstream effectors.
DNAX accessory molecule-1 (DNAM-1), also known as
CD226, is a receptor expressed on natural killer (NK) cells,
CD8+ T cells, some CD4+ T cells, and some myeloid cells
(Shibuya et al., 1996; Long et al., 2013; de Andrade et al.,
2014; Martinet and Smyth, 2015). Although it is part of the
Ig superfamily, DNAM-1 is rather unique. This uniqueness is
especially evident in the cytoplasmic domain, which shares
little or no homology with other Ig superfamily members.
DNAM-1 recognizes CD155 (poliovirus receptor) and
CD112 (nectin-2) as ligands, which are expressed on a broad
range of cells, including transformed cells and virus-infected
cells (Bottino et al., 2003). CD155, CD112, or both are also
ligands for the inhibitory receptors TIGIT and CD96 (tactile), which are also expressed on immune cells. As loss of
DNAM-1 enhances the availability of CD155 and CD112
for TIGIT and CD96, this feature complicates interpretation
of phenotypes found in mice lacking DNAM-1.
DNAM-1 was initially identified as a molecule promoting cytotoxicity and cytokine secretion by NK cells and
CD8+ T cells (Shibuya et al., 1996). Subsequent work revealed that DNAM-1 was important for NK cell–mediated
killing of tumor cells such as melanoma cells, rhabdomyosarcoma cells, and Ewing’s sarcoma cells (Verhoeven et al., 2008;
Lakshmikanth et al., 2009; Cho et al., 2010). Accordingly,
DNAM-1–deficient mice were more susceptible to carcinogen-induced fibrosarcoma and papilloma in vivo (Gilfillan
et al., 2008; Iguchi-Manaka et al., 2008). DNAM-1 was also

implicated in NK cell–mediated elimination of HIV-infected
CD4+ T cells and human cytomegalovirus (HCMV)-infected
DCs (Magri et al., 2011; Matusali et al., 2012). Moreover, in
mice, it played a critical role in expansion and survival of
virus-specific memory NK cells in mouse cytomegalovirus
(MCMV)–infected mice (Nabekura et al., 2014). A key role of
DNAM-1 was also documented in CD8+ T cells. DNAM-1
was critical for the ability of CD8+ T cells to eliminate tumor
cells and virus-infected cells during blocking antibody therapy targeting the inhibitory receptor TIGIT (Johnston et al.,
2014). Likewise, DNAM-1 was necessary for the ability of
CD8+ T cells to mediate acute graft-versus-host disease in
mice (Nabekura et al., 2010).
Early studies suggested that human DNAM-1 promotes
NK cell activation, at least in part, by acting as an adhesion
receptor, which stabilizes physical contacts between NK cells
and target cells (Shibuya et al., 1996, 1999). This function was
reportedly dependent on the ability of DNAM-1 to bind in
cis to integrin LFA-1. DNAM-1 was also shown to undergo
phosphorylation at a conserved tyrosine (Y) in its cytoplasmic domain (Y319 in mouse and Y322 in human; Shibuya et
al., 1999). This phosphorylation was reported to be mediated
by Src family kinase Fyn. Although the precise role of Y319
was not elucidated (for simplification, mouse numbering will
be used in this report), the ability of DNAM-1 to stimulate accumulation of virus-induced memory-like NK cells in
mice was dependent on Y319 (Nabekura et al., 2014). Human
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RESULTS
DNAM-1 triggers signals involving activation of Erk,
Akt, and calcium fluxes
To resolve the mechanism by which DNAM-1 promotes NK
cell activation, the ability of DNAM-1 to trigger intracellular
signals in the absence of engagement of other activating receptors was examined (Fig. 1). Stimulation of normal mouse NK
cells with anti–DNAM-1 antibodies (anti–DNAM-1) resulted
in activation of kinases Erk and Akt (Fig. 1 A). This was not a
result of triggering of CD16, an activating Fc receptor on NK
cells, as these effects were lost in NK cells from DNAM-1–deficient mice (Fig. 1 B).We also examined the ability of DNAM-1
to trigger calcium fluxes (Fig. 1, C and D). Normal mouse
NK cells contained both DNAM-1+ and DNAM-1− subsets,
as previously reported (Tahara-Hanaoka et al., 2005; Fig. 1 C).
2166

Stimulation with anti–DNAM-1 induced calcium fluxes in
DNAM-1+, but not in DNAM-1−, NK cells (Fig. 1 D).
Mouse DNAM-1 was also ectopically expressed in the
human NK cell line YT-S, which lacks CD16 (Fig. 1, E and
H; and not depicted). Triggering of mouse DNAM-1 on
YT-S cells resulted in activation of Erk and Akt (Fig. 1, E and
F). Additionally, it triggered calcium fluxes (Fig. 1 G). Importantly, expression of mouse DNAM-1 on YT-S also enabled killing of B16, a mouse melanoma cell line expressing
ligands for DNAM-1 (Dong et al., 2009), as well as RMA-S
mouse lymphoma cells ectopically expressing mouse CD155
(Fig. 1, E and H). No killing was seen toward RMA-S cells
lacking CD155, or when YT-S cells lacked mouse DNAM-1.
Consequently, in this experimental system, engagement of
DNAM-1 was strictly needed for target cell killing.
These data showed that engagement of DNAM-1 on
NK cells triggered active biochemical signals involving activation of Erk, Akt, and calcium fluxes.These signals correlated
with enhanced natural cytotoxicity.
Y319, but not S326, is critical for DNAM-1–mediated
signaling and cytotoxicity
To determine the mechanism by which DNAM-1 coupled
to these signals, we focused on the cytoplasmic domain. Although the sequence in this region is quite divergent across
species, there is a stretch of 5 aa, D/EIYV/MN (where D is aspartic acid, E is glutamic acid,V is valine, M is methionine, and
N is asparagine), that is highly conserved in all species, including mouse and human (Fig. 2 A). This sequence encompasses
the aforementioned site of phosphorylation,Y319 (Shibuya et
al., 1999). The other proposed phosphorylation site, S326, is
located outside of this motif (Shibuya et al., 1998). Moreover,
S326 is present in mouse and human, but not in other species.
To examine if these phosphorylation sites were critical for
the ability of DNAM-1 to trigger signals and promote cytotoxicity, mutants of mouse DNAM-1 carrying a tyrosine 319-to-phenylalanine 319 (Y319F) or a serine 326-to-alanine 326 (S326A)
mutation, two conserved substitutions aimed at preventing
phosphorylation without affecting structure, were introduced in
YT-S cells. Both mutants were expressed in amounts analogous
to those of WT DNAM-1 (Fig. 2 B).The Y319F mutation fully
abrogated the capacity of DNAM-1 to trigger activation of Erk
and Akt (Fig. 2 C). In contrast, the S326A substitution had no
effect. Likewise,Y319F, but not S326A, eliminated the capacity of
DNAM-1 to mediate cytotoxicity toward B16 cells or RMA-S
cells expressing CD155 (Fig. 2 D).
Hence, the highly conserved Y319, but not the less conserved S326, was needed for the ability of DNAM-1 to stimulate intracellular signals and cytotoxicity in YT-S cells.
Generation and analyses of DNAM-1
Y319F knock-in (KI) mouse
To establish the physiological relevance of this mechanism, a
KI mouse, in which Y319 was changed to phenylalanine in
the germline (Cd226Y319F mouse), was created (Fig. 3). The
DNAM-1 control of NK cell activation | Zhang et al.

Downloaded from jem.rupress.org on December 8, 2015

DNAM-1 was also described to undergo phosphorylation at
serine 326 (S326) in its cytoplasmic domain, as a result of the
action of protein kinase C (Shibuya et al., 1998, 1999). This
phosphorylation was reported to promote the DNAM-1–
LFA-1 association and, in mice, to be critical for accumulation
of memory-like NK cells in virus-infected mice (Shibuya et
al., 1999; Nabekura et al., 2014).
Various reports have examined the possibility that
DNAM-1 transduces intrinsic biochemical signals. In some
studies, engagement of human DNAM-1 by anti–DNAM-1
antibodies failed to trigger activation of kinases Erk and Akt
or calcium fluxes (Bryceson et al., 2006; Chen et al., 2007).
In other studies, human DNAM-1 synergized with 2B4 to
enhance tyrosine phosphorylation of adaptor SLP-76 and exchange factor Vav-1 (Kim and Long, 2012). This effect correlated with increased NK cell–mediated cytotoxicity and
cytokine production. However, the mechanism by which
DNAM-1 influenced these signals was not determined.
Whether DNAM-1 functions as an adhesion receptor, a
signal transduction molecule or both during NK cell activation needs to be resolved.The structural basis for the ability of
DNAM-1 to mediate possible signals, as well as the effectors
of these signals, also requires clarification. Lastly, the cellular
mechanism by which DNAM-1 promotes NK cell activation, i.e., enhanced cellular adhesion or other mechanisms,
requires clarification.
Herein, we addressed these issues using a combination
of genetic, biochemical, molecular, and imaging approaches.
These studies showed that engagement of DNAM-1 triggered
active signals, which were required for the ability to promote
NK cell activation. These signals were initiated by Y319, but
not S326, of DNAM-1. They also necessitated an asparagine
at position 321 (N321), which cooperated with phosphorylated Y319 to bind adaptor Grb2. Binding of DNAM-1 to
Grb2 enabled activation of exchange factor Vav-1, phosphatidylinositol (PI) 3′ kinase, and phospholipase C (PLC)-γ1.
DNAM-1 signaling did not enhance cytotoxicity by promoting adhesion. Rather, it acted by enhancing actin polymerization and polarization of lytic granules toward target cells.

Published November 9, 2015

construct depicted in Fig. 3 A was used to introduce the mutation in embryonic stem (ES) cells from C57BL/6 mice. After
germline transmission of the mutation, breeding of mutant
mice with animals expressing the Flpe recombinase eliminated
the neo selection cassette. As reported for DNAM-1–defiJEM Vol. 212, No. 12

cient mice (Gilfillan et al., 2008; Iguchi-Manaka et al., 2008),
DNAM-1 Y319F mice exhibited no alterations of NK cell
numbers, development, or repertoire (Fig. 3, B and C). These
mice also displayed unaltered levels of DNAM-1 on NK cells.
The proportion of DNAM-1+ NK cells was also not affected.
2167

Downloaded from jem.rupress.org on December 8, 2015

Figure 1. Impact of engagement of DNAM-1 on activation of Erk, Akt, and calcium fluxes in NK cells. (A) IL-2–activated NK cells from WT mice
were stimulated for 2 min with anti–mouse DNAM-1 (480.2), followed by secondary antibodies (+) or secondary antibodies alone (-). Activation of Erk
and Akt was assessed by immunoblotting with antibodies against phosphorylated Erk (α-pErk) or Akt (α-pAkt). Quantitation of relative phosphorylation is
shown at the bottom. Representative of at least n = 3. (B) Same as A, except that WT and DNAM-1–deficient (KO) mice were analyzed. Representative of at
least n = 3. (C) Expression of DNAM-1 on splenic NK cells (defined as NK1.1+CD3− cells) was analyzed by flow cytometry. Isotype control is shown as filled
histograms. Percentage of DNAM-1+ NK cells is indicated. Representative of at least n = 5. (D) IL-2–activated NK cells were labeled with FITC-conjugated
anti–mouse DNAM-1 and loaded with Indo-1, followed by secondary antibodies (stimulated) or not (unstimulated). The changes of intracellular calcium
(monitored as FL4/FL5 ratio) in DNAM-1+ (top) and DNAM-1− (middle) NK cells were analyzed. Cells were treated with ionomycin (bottom) as positive control. Arrow indicates when the secondary antibodies or ionomycin was added. Representative of n = 5. (E) Expression of mouse DNAM-1 (top) and mouse
CD155 (bottom) on transfected or retrovirus-transduced YT-S cells and RMA-S cells, respectively, was determined by flow cytometry. Cells expressing the
puromycin resistance marker (puro) or GFP alone were used as control. Isotype control is shown as filled histogram. Representative of at least n = 3. (F) YT-S
cells expressing mouse DNAM-1 (mDNAM-1) or puromycin-resistant marker (puro) alone were stimulated with anti–DNAM-1, and activation of Erk and Akt
was assessed, as detailed for A. Representative of n = 5. (G) YT-S cells expressing mouse DNAM-1 (mDNAM-1) or puromycin-resistant marker (puro) alone
were loaded with Indo-1. They were then stimulated with anti–mouse DNAM-1, followed by secondary antibodies (stimulated), or secondary antibodies
alone (unstimulated). Changes of intracellular calcium were monitored as FL4/FL5 ratio. Arrow indicates when the secondary antibodies or ionomycin was
added. Representative of n = 3. (H) Natural cytotoxicity of YT-S cells expressing mouse DNAM-1 (mDNAM-1) or puromycin resistant marker (puro) alone
was tested in a 51Cr-release assay at indicated effector-to-target (E/T) ratio. The target cells used were B16 or RMA-S expressing or not expressing mouse
CD155. SDs of duplicate values are depicted by error bars. Representative of n = 3.
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As was the case for NK cells lacking DNAM-1, NK cells
expressing DNAM-1 Y319F displayed compromised activation of Erk and Akt in response to anti–DNAM-1 (Fig. 3 D).
A markedly reduced ability to evoke calcium fluxes was also
observed (Fig. 3 E). Furthermore, like DNAM-1–deficient
NK cells, NK cells expressing DNAM-1 Y319F showed a reduced ability to kill the nonhematopoietic target cells B16
and Neuro-2a (neuroblastoma), which express ligands for
DNAM-1, but not for NKG2D (Dong et al., 2009; Fig. 4, A
and B). A defect was also seen toward CMT-93 (rectal carcinoma), which expresses ligands for DNAM-1 and NKG2D.
Notably, with these three targets, the defects observed with
DNAM-1 Y319F NK cells were slightly less severe than those
noted with DNAM-1–deficient NK cells. The possible significance of this finding will be discussed below. No defect
was seen in cytotoxicity toward RMA-S or YAC-1, either
with DNAM-1–deficient or with DNAM-1 Y319F NK cells.
We also tested the impact of the Y319F mutation on
production of IFN-γ (Fig. 4 C). Splenic NK cells were incubated or not with B16, and IFN-γ production was determined by intracellular staining. As was the case of lack
of DNAM-1, mutation of Y319F abrogated the ability of
DNAM-1 to promote IFN-γ production in response to B16.
No difference was seen when cells were activated with phorbol myristate acetate (PMA) and ionomycin, which trigger
cytokine production by bypassing activating receptors. Because only ∼50% of mouse NK cells express DNAM-1, we
2168

also compared production of IFN-γ by DNAM-1+ NK cells
from WT or DNAM-1 KI mice (Fig. 4 D). Compared with
WT NK cells, DNAM-1 KI NK cells displayed a markedly
attenuated IFN-γ production in the presence of B16.
Thus, as was the case in YT-S cells, mutation of Y319
severely attenuated the ability of DNAM-1 to mediate signals, as well as to promote cytotoxicity and cytokine production in mouse NK cells.
DNAM-1 promotes cytotoxicity via a tyrosine- and
asparagine-based motif that couples to Grb2
We postulated that, when phosphorylated, Y319 was coupling DNAM-1 to a specific set of intracellular signaling
molecules promoting NK cell activation. To identify these
effectors, we opted to use primarily the YT-S system, for
the following reasons. First, it was easier to generate large
numbers of YT-S cells for biochemical studies. Second,
our derivatives of YT-S cells uniformly expressed mouse
DNAM-1, whereas only ∼50% of mouse NK cells expressed DNAM-1 and this fraction was further diminished
when NK cells were expanded in IL-2 (unpublished data).
Third, stimulation of mouse DNAM-1 on YT-S cells generated signals (activation of Erk, Akt, and calcium fluxes) analogous to those seen in normal mouse NK cells. Moreover,
in both systems, these signals were dependent on Y319. And
fourth, YT-S cells were ideal for structure–function analyses
of DNAM-1, as expression of mouse DNAM-1 in these
DNAM-1 control of NK cell activation | Zhang et al.
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Figure 2. Y319, but not S326, is required for DNAM-1–dependent natural cytotoxicity. (A) Alignment of the C-terminal sequence of DNAM-1 from
various species. Amino acids that are strictly conserved are highlighted in dark gray. Partially conserved residues are shown in lighter gray. The positions of
tyrosine 319 (Y319) and serine 326 (S326) in the mouse sequence (indicated by asterisks) are shown. (B) Expression of DNAM-1 on YT-S cells transfected
with cDNAs encoding WT mouse DNAM-1 or mouse DNAM-1 mutants carrying a tyrosine 319-to-phenylalanine 319 (Y319F) or serine 326-to-alanine
326 (S326A) substitution was determined by flow cytometry. Cells expressing the puromycin resistant marker (puro) alone are included as control. Isotype
controls are shown as filled histograms. Representative of n = 4. (C) The YT-S cells described in B were stimulated with anti–DNAM-1 and activation of
Erk and Akt was assessed, as detailed for Fig. 1 F. Quantitation of relative phosphorylation is shown at the bottom. Representative of n = 3. (D) The YT-S
cells described in B were tested for natural cytotoxicity, as detailed for Fig. 1 H. SDs of duplicate values are depicted by error bars. Representative of n = 4.
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Figure 3. Generation and signaling analyses of mice expressing DNAM-1 Y319F. (A) The genomic structure of the DNAM-1–encoding gene in the
mouse, Cd226, is shown at the top. Tyrosine 319 (Y319) is encoded by exon 7, which also contains the stop codon. The targeting construct is shown in
the middle. In this construct, the WT codon for Y319, TAT, was replaced by a codon for phenylalanine, TTT. The final Y319F knock-in (KI) Cd226 allele carrying
the mutated codon is shown at the bottom. (B) Splenocytes from WT, DNAM-1–deficient (KO), or DNAM-1 Y319F (KI) mice were analyzed by flow cytometry.
Proportions of NK cells (NK1.1+CD3− cells) are indicated (left). Expression of CD11b, CD27, and DNAM-1 on NK cells was also analyzed (middle and right).
Percentages of NK cells in each quadrant (middle), as well as of DNAM-1+ NK cells (right), are shown. Isotype controls are depicted as filled histogram.
Representative of n = 4. (C) Expression of various receptors was analyzed on NK1.1+CD3− splenocytes from WT, KI, or KO mice, using flow cytometry. Isotype
controls are shown as the red line. Representative of n = 2. (D) Same as Fig. 1 A, except that WT, DNAM-1 KO, and DNAM-1 KI NK cells were analyzed. Quantitation of relative phosphorylation is shown at the bottom. Representative of n = 3. (E) Same as Fig. 1 D, except that only DNAM-1+ NK cells were analyzed.
Arrow indicates when the secondary antibodies or ionomycin was added. Uns, unstimulated; Sti, stimulated. Representative of n = 3.

cells was absolutely required for killing of mouse target cells
expressing DNAM-1 ligands.
To identify effectors that directly interacted with
DNAM-1, peptides corresponding to aa 315–333 in the
cytoplasmic domain of mouse DNAM-1 were synthesized,
JEM Vol. 212, No. 12

phosphorylated or not at Y319 (Fig. 5 A). After immobilization onto agarose beads, peptides were used to capture
binding proteins from lysates of YT-S cells (Fig. 5 B). Bound
proteins were identified by silver staining of protein gels. A
single polypeptide of ∼25 kD (p25) was bound to the peptide
2169
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Figure 4. Cytotoxicity and cytokine production by DNAM-1 Y319F mouse NK cells. (A) Natural cytotoxicity of NK cells from WT, DNAM-1 KO, or
DNAM-1 KI mice was tested in a 51Cr-release assay, using as targets B16, Neuro-2a, CMT-93, RMA-S, or YAC-1. SDs of duplicate values are depicted by error
bars. Representative of n = 5. (B) Expression of ligands for DNAM-1 and NKG2D on target cells. Expression of the DNAM-1 ligands, CD155 and CD112, and
NKG2D ligands (detected using an NKG2D-Fc fusion protein) was assessed by flow cytometry. Isotype controls are shown as the red line. Representative
of n = 3. (C and D) Splenocytes from poly(I:C)-primed mice were incubated with B16 for 6 h. Production of IFN-γ in total NK cells (NK1.1+CD3−; C) or
DNAM-1+ NK cells (NK1.1+CD3−DNAM-1+; D) was analyzed by intracellular staining. Splenocytes without any target or splenocytes stimulated with phorbol
myristate acetate and ionomycin (PMA/iono) served as controls. Representative dot plots are shown in C (left). Average values with SDs of triplicates from
one representative experiment are depicted in C (right) and D. Unpaired Student’s t tests were performed. **, P < 0.01. Representative of n = 3 (C and D).

phosphorylated at Y319, but not to the unphosphorylated
peptide. Mass spectrometry revealed that p25 was Grb2, an
intracellular adaptor composed of one Src homology 2 (SH2)
domain flanked by two Src homology 3 (SH3) domains
(Lowenstein et al., 1992; Pawson and Scott, 1997).The ability
of the phosphorylated DNAM-1 peptide to bind Grb2 was
2170

confirmed by immunoblotting of peptide-associated proteins
with anti-Grb2 antibodies (Fig. 5 C).
Phosphorylated Y319 (pY319) is nested in the sequence
pYVNY, which is compatible with the consensus binding
motif for the SH2 domain of Grb2, pYxNx (where x is any
residue; Songyang et al., 1994). Accordingly, the phosphoryDNAM-1 control of NK cell activation | Zhang et al.
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Figure 5. DNAM-1 promotes NK cell activation via a tyrosine- and asparagine-based motif that recruits Grb2. (A) Biotinylated peptides corresponding to the carboxyl-terminus of mouse DNAM-1 were synthesized, with (pY319) or without (Y319) phosphorylation at tyrosine 319. In some peptides, additional
mutations were introduced: N321Q, in which asparagine 321 was mutated to glutamine and Y322F, in which tyrosine 322 was mutated to phenylalanine. The
mutated residues are indicated by arrows. (B) DNAM-1 peptides were coupled to agarose beads and used to capture binding proteins from lysates of YT-S cells.
Bound proteins were identified by silver staining of protein gels. Agarose beads alone (no pep) served as control. The migration of molecular mass markers is indicated on the left. Representative of n = 4. (C) DNAM-1 peptides were incubated with lysates of YT-S cells and bound proteins were probed by immunoblotting
with anti-Grb2 antibodies. Representative of n = 4. (D) DNAM-1 peptides were incubated with lysates of bacteria expressing the indicated glutathione-S-transferase (GST) fusion proteins. Nonpurified GST-Grb2 SH2 fusion proteins served as control. Representative of n = 2. (E and F) YT-S cells were transfected with
cDNAs encoding WT, Y319F, N321Q, or Y322F mouse DNAM-1, or the puromycin resistant marker (puro) alone. Expression of mouse DNAM-1 was tested
by flow cytometry. Isotype controls are shown as filled histogram (E). Representative of n = 4. They were then stimulated (+) or not (−) with anti–DNAM-1
antibodies and the relevant secondary antibody (F). The association of DNAM-1 with Grb2 was detected by immunoblotting of DNAM-1 immunoprecipitates
with anti-Grb2 antibodies. Migration of heavy chain of IgG is shown on the left. Representative of n = 3. (G) The YT-S cells described in Fig. 5 E were tested for
natural cytotoxicity, as detailed for Fig. 1 H. SDs of duplicate values are depicted by error bars. Representative of n = 3. (H and I) YT-S cells expressing WT mouse
DNAM-1 were transfected with Grb2-specific siRNAs (siGrb2 #1) or irrelevant siRNAs (siCtr) as control. Down-regulation of Grb2 expression was assessed by
immunoblotting with anti-Grb2 (H). Cells were also tested for natural cytotoxicity, as detailed for Fig. 1 H (I). SDs of duplicate values are depicted by error bars.
Quantitation of relative protein expression is shown at the bottom (H). Representative of n = 4.

JEM Vol. 212, No. 12
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Grb2 couples DNAM-1 to Vav-1, PI3′K, and PLC-γ1
Next, we postulated that, whereas the SH2 domain of Grb2
interacted with tyrosine-phosphorylated DNAM-1, one
or both of its SH3 domains were involved in recruitment
of downstream effectors. To identify these effectors, several approaches were taken. First, DNAM-1 was immunoprecipitated from YT-S cells expressing WT DNAM-1 or
2172

DNAM-1 Y319F, stimulated or not with anti–DNAM-1.
DNAM-1–associated proteins were then detected by immunoblotting with antiphosphotyrosine antibodies (Fig. 6 A).
Immunoprecipitates of WT DNAM-1 from stimulated cells
contained tyrosine phosphorylated proteins of ∼45–50 kD
(p45-50) and ∼95 kD (p95). Both products were less prominently detectable in unstimulated cells and were absent in
cells bearing DNAM-1 Y319F.
Whereas p45-50 was likely DNAM-1 itself, p95 was
suggestive of Vav-1, an exchange factor known to associate
with Grb2 SH3 domains (Ramos-Morales et al., 1994; Bustelo, 2001). To address if p95 was Vav-1, denatured eluates of
DNAM-1 immunoprecipitates were reimmunoprecipitated
with anti–Vav-1 antibodies.Tyrosine-phosphorylated proteins
were then detected by antiphosphotyrosine immunoblotting
(Fig. 6 B). Tyrosine-phosphorylated p95 was recovered by
reimmunoprecipitation with anti–Vav-1 antibodies, but not
with normal rabbit serum. This experiment confirmed that
the DNAM-1–associated p95 was Vav-1.
We then evaluated whether other known regulators of
NK cell activation were tyrosine phosphorylated in response
to DNAM-1 engagement by immunoprecipitating total cell
lysates with substrate-specific antibodies, followed by antiphosphotyrosine immunoblotting (Fig. 6 C). Engagement of
WT DNAM-1 triggered tyrosine phosphorylation not only
of Vav-1, but also of phospholipase (PLC)-γ1, ubiquitin ligase c-Cbl, and lipid phosphatase SHIP-1. There was no impact on tyrosine phosphorylation of kinase Syk or adaptor
SLP-76 (Fig. 6 C; not depicted). These signals were absent
in cells containing DNAM-1 Y319F or DNAM-1 N312Q.
Mutation of Y319F also abolished the ability of DNAM-1 to
increase intracellular calcium, which is a downstream effector of PLC-γ1 (Fig. 6 D). It should be noted that PLC-γ1,
c-Cbl, and SHIP-1 were not detectably associated with
DNAM-1 (unpublished data).
Next, activation of Akt in response to DNAM-1 (Fig. 1)
raised the possibility that DNAM-1 also stimulated PI3′K, a
key upstream regulator of Akt. Because the Grb2 SH3 domains can bind to the PI3′K regulatory subunit p85 (Wang
et al., 1995), we examined whether engagement of DNAM-1
triggered recruitment of p85 to DNAM-1 (Fig. 6 E). Triggering of WT DNAM-1, but not DNAM-1 Y319F, induced
coimmunoprecipitation of DNAM-1 with p85. This effect
was absent in cells lacking DNAM-1.
Finally, to help identify the signals playing key roles
in DNAM-1–mediated cytotoxicity, YT-S cells expressing
mouse DNAM-1 were treated with various pharmacological
inhibitors, and the impact on cytotoxicity toward RMA-S
cells expressing CD155 was determined (Fig. 6, F and G).This
system was chosen because killing of the target cell variant
was strictly dependent on DNAM-1 function in YT-S cells
(Fig. 1 H). Wortmannin, a PI3′K inhibitor, caused a profound
suppression of cytotoxicity mediated by DNAM-1 (Fig. 6 F
and not depicted). A less prominent effect was seen with
1,2-bis(2-aminophenoxy)ethane-N,N,N′,N′-tetraacetic acid
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lated DNAM-1 peptide bound to recombinant Grb2 SH2
domains in vitro (Fig. 5 D). Moreover, the association between the phosphorylated DNAM-1 peptide was eliminated
when the highly conserved asparagine at the +2 position was
mutated to glutamine (N321Q mutation; Fig. 5, C and D).
However, it was not affected when the less conserved residue
at +3 position (Y322) was altered (Y322F mutation).
To show that DNAM-1 associated with Grb2 via the
pYxNx motif in cells,YT-S cells expressing WT,Y319F, N321Q,
or Y322F DNAM-1 were created and stimulated with anti–
DNAM-1 (Fig. 5, E and F).The association of DNAM-1 with
Grb2 was detected by immunoblotting of anti–DNAM-1 immunoprecipitates with anti-Grb2 (Fig. 5 F). WT DNAM-1
coimmunoprecipitated with Grb2 in cells stimulated with anti–
DNAM-1 antibodies. Minimal association was seen in unstimulated cells. As shown in the aforementioned in vitro binding
assays, this association was abolished by the Y319F or N321Q,
but not the Y322F, mutation. All mutants were expressed in
amounts analogous to those of WT DNAM-1 (Fig. 5 E).
To ascertain if Grb2 binding was critical for the activating function of DNAM-1, we first tested the ability of
these various DNAM-1 mutants to promote cytotoxicity
(Fig. 5 G). As was the case for mutation of Y319, the N321Q
mutation eliminated the ability of DNAM-1 to enhance
cytotoxicity toward B16, Neuro-2a, and CD155-expressing
RMA-S. In contrast, the Y322F mutation had no effect.
Next, we ascertained the impact of reduced Grb2 expression on DNAM-1 function. Unfortunately, these experiments
could not be performed with NK cells from Grb2-deficient
mice, as lack of Grb2 interfered with proper NK cell development in mice (unpublished data). Hence, we down-regulated
expression of Grb2 in YT-S cells, using siRNAs (Fig. 5, H
and I; and not depicted).Two different Grb2-specific siRNAs,
but not control siRNAs, induced an ∼40–70% diminution of
Grb2 expression in YT-S cells (Fig. 5 H; and not depicted).
Importantly, they also caused a reduction of cytotoxicity toward B16 and RMA-S cells expressing CD155 (Fig. 5 I; and
not depicted). As the ability of YT-S cells to kill RMA-S cells
expressing CD155 was strictly dependent on expression of
DNAM-1 on YT-S cells (Fig. 1 H), the latter finding supported the notion that Grb2 was directly implicated in the
activating function of DNAM-1.
Combined, these results showed that phosphorylation of the highly conserved tyrosine- and asparagine-based
motif of DNAM-1 resulted in recruitment of Grb2, which
was needed for the ability of DNAM-1 to promote NK
cell–mediated cytotoxicity.
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Figure 6. The tyrosine- and asparagine-based motif couples DNAM-1 to multiple effectors. (A) YT-S cells expressing WT
or Y319F mouse DNAM-1 were stimulated for
the indicated times with anti–DNAM-1 and
the relevant secondary antibody. DNAM-1 was
then immunoprecipitated from cell lysates, and
DNAM-1–associated proteins were detected
by immunoblotting with anti-phosphotyrosine
antibodies (α-P.tyr). The positions of DNAM-1
and p95 are indicated on the right. Migration
of prestained molecular weight markers and
heavy chain of IgG is shown on the left. It is
notable that the amount of DNAM-1 recovered from cells expressing WT DNAM-1, but
not DNAM-1 Y319F, was diminished upon
anti–DNAM-1 stimulation. This finding likely
indicated that signaling-competent DNAM-1
became detergent-insoluble upon stimulation.
Representative of n = 4. (B) YT-S cells expressing the indicated variants of DNAM-1 were
stimulated for 15 s with anti–DNAM-1 antibodies and the relevant secondary antibody.
After extensive washing, eluates of DNAM-1
immunoprecipitates were reimmunoprecipitated with anti-Vav-1 or normal rabbit serum
(NRS). Tyrosine phosphorylated proteins were
detected by anti-phosphotyrosine immunoblotting. Representative of n = 3. (C) YT-S cells
expressing the indicated variants of DNAM-1
or the puromycin resistance marker (puro)
alone were stimulated with anti–DNAM-1 followed by the relevant secondary antibodies.
Lysates were then immunoprecipitated with
antibodies against the specified substrates and
tyrosine phosphorylation was analyzed by immunoblotting with α-P.tyr. Quantitation of relative phosphorylation is shown at the bottom.
Representative of at least n = 3. (D) YT-S cells
expressing the indicated variants of DNAM-1
or the puromycin resistance marker (puro)
alone were stimulated with anti–DNAM-1 antibodies and the relevant secondary antibody.
Changes in intracellular calcium were analyzed
as described for Fig. 1 G. Representative of n = 3.
(E) YT-S cells expressing the indicated variants of DNAM-1 or the puromycin resistance
marker (puro) alone were stimulated for 15 s with anti–DNAM-1 antibodies and the relevant secondary antibody. DNAM-1 was then immunoprecipitated
and its association with p85 was detected by immunoblotting with anti-p85. Representative of n = 3. (F and G) YT-S cells expressing WT mouse DNAM-1
were treated with wortmannin (0.1 µM), 1,2-bis(2-aminophenoxy)ethane-N,N,N′,N′-tetraacetic acid tetrakis(acetoxymethyl ester; BAPTA-AM; 40 µM),
U0126 (1 µM), ibrutinib (10 nM), or dimethysulfoxide (DMSO) alone as control, and their capacity to kill RMA-S-CD155 cells was assessed in a 51Cr-release
assay (left). Average values at the 25:1 E/T ratio from 5 independent experiments are shown on the right. Representative of n = 5 (F) or n = 3 (G). SDs of
duplicate values are depicted by error bars. Unpaired Student’s t tests were performed. n.s., not statistically significant. *, P < 0.05; ***, P < 0.001. (H) Splenocytes from WT mice were stimulated with B16 cells in the presence of the indicated compounds, as detailed for H. Expression of CD107a on DNAM-1+ NK
cells (NK1.1+CD3−DNAM-1+) was analyzed by flow cytometry. Splenocytes alone or splenocytes stimulated with phorbol myristate acetate and ionomycin
(PMA/iono) served as controls. Average values with SDs of triplicate values from one representative experiment are depicted. Unpaired Student’s t tests were
performed. ***, P < 0.001; ****, P < 0.0001. Representative of n = 3.
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Fyn and LFA-1 are not critical for DNAM-1 signaling
Previous studies suggested that Fyn was critical for phosphorylation of DNAM-1 at Y319 and, thus, for DNAM-1
function (Shibuya et al., 1999). To assess if Fyn was needed
for DNAM-1 signaling, the ability of DNAM-1 to mediate
signals and enhance cytotoxicity was examined in NK cells
from Fyn-deficient mice (Fig. 7, A–C). Fyn deficiency had
no impact on DNAM-1 expression on NK cells (Fig. 7 A).
More importantly, it had little or no effect on the capacity
of DNAM-1 to trigger activation of Erk and Akt (Fig. 7 B).
Nonetheless, as previously reported, loss of Fyn reduced
the ability of NK cells to kill a broad range of targets
(Bloch-Queyrat et al., 2005; Dong et al., 2012; Fig. 7 C).
This effect was seen whether target cells expressed or not
DNAM-1 ligands. These findings indicated that Fyn was not
absolutely required for the signaling capacity of DNAM-1.
However, it was needed for NK cell–mediated cytotoxicity,
presumably by receptors other than DNAM-1.
It was also proposed that LFA-1 was critical for the capacity of DNAM-1 to promote NK cell functions (Shibuya
et al., 1999).To examine if LFA-1 was required for DNAM-1
signaling, the function of DNAM-1 was examined in NK
cells from LFA-1–deficient mice (Fig. 7, D–F). Lack of LFA-1
had no impact on DNAM-1 expression (Fig. 7 D). Surprisingly, it also had no effect on the capacity of DNAM-1 to
activate Erk and Akt (Fig. 7 E). However, lack of LFA-1 reduced the ability of NK cells to kill some, but not all, target
cells. As was the case for Fyn deficiency, this effect was seen
whether target cells did or did not express DNAM-1 ligands.
In particular, an effect was seen on RMA-S, which expressed
ICAM-1 and ICAM-2, but did not express DNAM-1 ligands
(Fig. 7 F). In contrast, there was no impact on B16 and CMT93, which had little or no ICAM-1 and ICAM-2 (Fig. 7 G),
2174

but were killed in a DNAM-1–dependent manner (Fig. 4).
These findings implied that LFA-1 was not strictly needed for
the signaling capabilities and activating function of DNAM-1.
Next, we determined which classes of PTKs were responsible for phosphorylation of Y319 of DNAM-1 (Fig. 7,
H and I). Co-transfection experiments in Cos-1 cells revealed that Src family kinases Fyn and, to a lesser extent, Lyn,
Src, and Lck, were able to trigger tyrosine phosphorylation
of DNAM-1 (Fig. 7 H). No phosphorylation was induced
by Syk and ZAP-70, which belong to a distinct PTK family.
In the light of these results, we examined the impact of Src
family kinase inhibitor PP2 on tyrosine phosphorylation of
DNAM-1 in NK cells (Fig. 7 I).Treatment of YT-S cells with
PP2 fully prevented the ability of anti–DNAM-1 to induce
tyrosine phosphorylation of DNAM-1 and the associated
Vav-1. It also suppressed the ability of anti–DNAM-1 to trigger the association of DNAM-1 with Grb2.
Thus, although Fyn and LFA-1 played a key role
in activation via a wide range of activating receptors, they
were not strictly required for DNAM-1 signaling. Furthermore, multiple Src family kinases, including not only Fyn
but also Lyn, Src, and Lck, were able to trigger DNAM-1
tyrosine phosphorylation.
DNAM-1 signaling promotes actin polymerization
and granule polarization
DNAM-1 was shown to serve at least in part as an adhesion
receptor, which promotes NK cell activation by stabilizing
conjugate formation between NK cells and target cells, one
of the key steps of NK cell synapse formation (Shibuya et
al., 1996; Orange, 2008). To assess if this function required
DNAM-1 signaling and was sufficient to promote NK cell
activation, we evaluated the impact of DNAM-1 and its signaling motif on various steps of NK cell–mediated cytotoxicity (Fig. 8). First, conjugate formation between NK cells and
target cells was analyzed, using YT-S cells expressing various
forms of mouse DNAM-1 and a flow cytometry–based assay
(Fig. 8, A–C). WT DNAM-1 markedly enhanced the ability of NK cells to form stable conjugates with RMA-S cells
expressing mouse CD155 (Fig. 8 A). Surprisingly, however,
the signaling-defective DNAM-1 Y319F and N321Q mutants also increased conjugate formation, even though they
did not promote cytotoxicity. A time-course analysis and a
quantitation are depicted in Fig. 8 B. The signaling-competent DNAM-1 S326A mutant behaved like WT DNAM-1 in
this assay (Fig. 8 C).
This observation implied that the ability of DNAM-1
to enhance adhesion was not sufficient to promote cytotoxicity. In this light, we examined the impact of DNAM-1 on
subsequent events of NK cell activation, in particular actin
polymerization and polarization of lytic granules, using confocal microscopy (Orange, 2008; Fig. 8, D–F). YT-S cells
expressing WT DNAM-1, DNAM-1 Y319F, DNAM-1
N321Q, or DNAM-1 S326A were incubated with RMA-S
cells expressing mouse CD155 for a fixed amount of time.
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tetrakis(acetoxymethyl ester; BAPTA-AM), a calcium chelator. However, no impact was observed with U0126, an inhibitor of the Erk pathway, or ibrutinib, an inhibitor of the
kinase Btk (Fig. 6, F and G). These various compounds had
no deleterious effect on cell viability (unpublished data).
To provide evidence that PI3′K was also involved in
DNAM-1–dependent degranulation in primary NK cells, we
tested the effect of two PI3′K inhibitors, wortmannin and
Ly294002, on the ability of primary mouse NK cells to expose CD107a, a marker of granule exocytosis, in response to
B16 melanoma cells (Fig. 6 H). Treatment with either inhibitor resulted in significant inhibition on the increased CD107a
exposure in response to B16 cells.
As Vav-1, c-Cbl, SHIP-1, and p85 bind the Grb2 SH3
domains (Ramos-Morales et al., 1994; Odai et al., 1995;
Kavanaugh et al., 1996), these findings supported that idea
that Grb2 was responsible for coupling DNAM-1 to these
effectors. Our data with pharmacological inhibitors also suggested that activation of PI3′K and, to a lesser extent, calcium fluxes (a PLC-γ1 effector) were especially important for
DNAM-1–dependent cytotoxicity.
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Figure 7. Role of Fyn and LFA-1 in DNAM-1 signaling. (A) Expression of DNAM-1 was analyzed on NK cells (NK1.1+CD3− splenocytes) from WT and
Fyn-deficient (KO) mice. Isotype control is shown as filled histogram. Representative of n = 4. (B) NK cells from the indicated mice were stimulated
for 2 min with anti–DNAM-1 antibodies and the relevant secondary antibody. Phosphorylation of Erk and Akt was assessed as detailed for Fig. 1 A. Quantitation of relative phosphorylation is shown at the bottom. Representative of n = 2. (C) Natural cytotoxicity of NK cells toward a variety of targets was tested
in a 51Cr-release assay at indicated effector-to-target (E/T) ratio. SDs of duplicate values are depicted by error bars. Representative of n = 4. (D–F) Same as
A–C, except that WT and LFA-1–deficient (KO) mice were analyzed. Representative of n = 3. (G) Expression of LFA-1 ligands on the indicated targets was
determined by flow cytometry. Red line, isotype control. Representative of n = 2. (H) Mouse DNAM-1 was coexpressed with the indicated protein tyrosine
kinases (PTKs) in Cos-1 cells. DNAM-1 was then immunoprecipitated and probed by immunoblotting with anti-phosphotyrosine (α-P.tyr) antibodies. Expression of PTKs was detected by probing total cell lysates with a cocktail of antibodies against the various PTKs. Representative of n = 3. (I) YT-S cells expressing
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DISCUSSION
Herein, we examined whether DNAM-1 mediates intrinsic
signals and whether these signals are critical for DNAM-1
to promote NK cell activation. Our initial studies showed
that engagement of mouse DNAM-1 on NK cells by anti–
DNAM-1 antibodies resulted in activation of Erk, Akt and
calcium fluxes, three positive regulators of NK cell activation. This effect was seen in normal mouse NK cells and
the human NK cell line YT-S. It was strictly dependent on
DNAM-1 expression on NK cells, implying that it was truly
mediated by engagement of DNAM-1, rather than by nonspecific triggering of other receptors such as Fc receptors.
It is possible that the inability to detect these signals in an
earlier study using a human NK cell line was due to differences in stimulation protocols or in the NK cell populations
studied (Chen et al., 2007).

Structure–function analyses provided strong evidence
that DNAM-1–mediated signals were crucial for the capacity to promote NK cell activation. In particular, mutation of
Y319, a site of tyrosine phosphorylation in the cytoplasmic
domain of DNAM-1, completely abrogated the ability of
DNAM-1 to signal and promote cytotoxicity in YT-S cells.
Interestingly, similar effects were seen when an asparagine located at the +2 position vis-à-vis Y319, N321, was mutated.
In contrast, no effect was seen when a less conserved site of
phosphorylation, S326, was mutated. Thus, the tyrosine- and
asparagine-containing motif, but not S326, was necessary for
the ability of DNAM-1 to signal and promote NK cell activation. Both Y319 and N321 are highly conserved across species.
Introduction of the DNAM-1 Y319F mutation in the
mouse germline also dramatically reduced the capacity of
DNAM-1 to trigger signals, natural cytotoxicity, and cytokine
production in mouse NK cells. This observation validated the
findings made in YT-S cells. It should be mentioned, however, that the Y319F mutation did not completely eliminate
all functions of DNAM-1 in mouse NK cells. A small residual activity seemingly remained. In comparison to NK cells
lacking DNAM-1, cells expressing DNAM-1 Y319F had a
slightly less compromised ability to mediate cytotoxicity toward B16 and Neuro-2a. Furthermore, DNAM-1 Y319F was
capable of triggering a small degree of calcium flux, although
this response was much weaker than that evoked by WT
DNAM-1. Thus, in mouse NK cells, the Y319F mutant was
capable of mediating some signals, albeit much more weakly
than WT DNAM-1. It is possible that this residual activity related to the existence of an additional minor signaling motif,
which might be active in mouse NK cells but not in YT-S
cells. Future studies will be needed to address this possibility.
The molecular mechanism by which the tyrosineand asparagine-containing motif triggered signals was next
characterized. Immunoprecipitation experiments in YT-S
cells showed that engagement of DNAM-1 triggered tyrosine phosphorylation of DNAM-1. This phosphorylation was abolished when Y319 was mutated, implying that
it occurred at Y319. Engagement of DNAM-1 also induced tyrosine phosphorylation of Vav-1, PLC-γ1, c-Cbl,
and SHIP-1. All these events were eliminated when either
Y319 or N321 was mutated.
Several lines of evidence indicated that the tyrosineand asparagine-based motif was promoting NK cell activation by linking DNAM-1 to Grb2. First, the tyrosine- and
asparagine-based motif is a typical consensus binding sequence for the Grb2 SH2 domain (pYxNx; Songyang et al.,
1994). Second, Grb2 was the sole polypeptide recovered with
a peptide encompassing phosphorylated Y319 and N321 of

mouse DNAM-1 were stimulated for 15 s with anti–DNAM-1 and the relevant secondary antibodies, in the absence or in the presence of the indicated
concentrations of the Src family kinase inhibitor, PP2. DNAM-1 then was recovered from cell lysates by immunoprecipitation and probed by immunoblotting
with anti-phosphotyrosine (α-P.tyr) or anti-Grb2 antibodies. Treatment with DMSO alone served as control (Ctr). The migration of molecular mass markers
is indicated on the left. Representative of n = 3.
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They were then stained with fluorescent phalloidin, to detect polymerized actin, and antibodies against perforin and
tubulin to detect lytic granules and microtubule-organizing
centers, respectively. Target cells were also distinguished from
NK cells, by labeling the former with CellTrace violet. Examples of conjugates in which NK cells displayed polarized
or nonpolarized granules are depicted in Fig. 8 D.
In keeping with the aforementioned results, conjugates between NK cells and target cells were more abundant
when YT-S cells expressed any of the DNAM-1 variants,
compared with cells lacking DNAM-1 (unpublished data).
However, among these conjugates, NK cells expressing WT
DNAM-1 and DNAM-1 S326A exhibited more frequent
actin polymerization and polarized granules, in comparison
to cells expressing the signaling-defective DNAM-1 Y319F
and N322Q (Fig. 8, E and F).
Primary mouse NK cells are difficult to analyze by confocal microscopy. To show that DNAM-1 signaling also enhanced granule polarization in mouse NK cells, we evaluated
externalization of CD107a in NK cells from WT, DNAM-1–
deficient, or DNAM-1 Y319F mice (Fig. 8, G and H). Compared with WT NK cells, NK cells from DNAM-1–deficient
or DNAM-1 Y319F mice exhibited diminished CD107a exposure in response to B16 targets (Fig. 8 G). No difference
was seen in response to PMA and ionomycin. Similar results
were obtained when only DNAM-1+ NK cells from WT and
DNAM-1 Y319F mice were compared (Fig. 8 H).
Therefore, augmentation of NK cell adhesion by
DNAM-1 was signaling-independent and insufficient to promote cytotoxicity. DNAM-1 signaling enhanced NK cell cytotoxicity by favoring actin polymerization and lytic granule
polarization, rather than by enhancing conjugate formation.
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Figure 8. Impact of DNAM-1 signaling on conjugate formation, actin polymerization, and granule polarization. (A–C) The indicated derivatives
of YT-S cells (labeled with Brilliant Violet 421-conjugated anti–human NKp46) were incubated with RMA-S-GFP or RMA-S-CD155 (labeled with Alexa Fluor
647–conjugated anti–mouse SLAM). Formation of conjugates (identified as NKp46+SLAM+) at the indicated times was examined by flow cytometry. A representative experiment is shown in A. The percentages of conjugates formed are indicated at the top. Statistical analysis of one representative experiment with
SD of duplicate values is shown in B and C. Representative of at least n = 3. (D–F) Derivatives of YT-S cells and CellTrace violet-loaded RMA-S-CD155 cells
were incubated for 30 min, loaded on poly-L-lysine–coated slides, and stained with phalloidin, anti-perforin, and anti-tubulin. Conjugates were analyzed
by confocal microscopy. Staining of representative conjugates in which cytotoxic granules of YT-S cells were polarized or nonpolarized toward the synapse

JEM Vol. 212, No. 12

2177

Published November 9, 2015

Fyn and LFA-1 were previously suggested to play
key roles in the function of human DNAM-1 (Shibuya et
al., 1999). However, using NK cells from Fyn-deficient or
LFA-1–deficient mice, we observed that Fyn and LFA-1
were not strictly needed for DNAM-1 signaling. Nonetheless, as reported, both were necessary for NK cell activation
in response to various targets, whether targets did or did
not express ligands for DNAM-1 (Matsumoto et al., 1998;
Bloch-Queyrat et al., 2005; Dong et al., 2012). This finding
implied that Fyn and LFA-1 were needed for the function
of activating receptors other than DNAM-1. Based on transfection assays in Cos-1 cells, it is probable that, in addition
to Fyn, other members of the Src family, such as Lyn, Src,
and Lck, participated in DNAM-1 signaling, at least in the
mouse. Likewise, it is likely that, in addition to LFA-1, other
integrins were implicated in DNAM-1–dependent killing.
This is especially true for targets such as B16 and CMT-93,
which were killed in a DNAM-1–dependent manner but
lacked ligands for LFA-1.
Although our data showed that the highly conserved
Y319, but not the less conserved S326, was needed for the
capacity of mouse DNAM-1 to mediate signals and promote NK cell cytotoxicity, Nabekura et al. (2014) recently
showed that both Y319 and S326 were critical for mouse
DNAM-1–dependent accumulation of memory NK cells in
MCMV-infected mice. One possible explanation for these
divergent results is that signals emanating from S326 are not
needed for natural cytotoxicity, but are required for expansion
of memory-like NK cells. It is also plausible that these different findings reflected distinctions in experimental conditions
or systems. We mutated S326 to alanine (a conserved substitution) and tested the function of this mutant in the human
YT-S cell line. Alternatively, Nabekura et al. (2014) replaced
S326 by phenylalanine and studied the activity of this mutant
in a competitive assay using bone marrow–reconstituted mice.
Although DNAM-1 may be strictly speaking the sole
member of its family, other activating and co-stimulatory
receptors use Grb2 as their immediate effector, by way of
a sequence christened immunoglobulin tyrosine tail (ITT)
motif (Engels et al., 2009; Engels and Wienands, 2011). These
ITT motif-containing receptors include NKG2D, CD28,
and membrane-bound IgG. Whereas DNAM-1 interacted
with Grb2 by way of the sequence pYVNY (critical residues are underlined; this study), NKG2D interacts with Grb2
via the motif pYINM found in the NKG2D-associated

are shown in D. Bars, 10 µm. Percentages of conjugates in which YT-S cells displayed polymerized actin near the synapse or polarized granules are shown
in E and F. For each YT-S derivative, >100 conjugates were analyzed. Averages of four values for each cell type pooled from two independent experiments
are depicted in E and F. SDs are shown by error bars. Unpaired Student’s t tests were performed. n.s., non significant. **, P < 0.01; ***, P < 0.001. (G and H)
Splenocytes from the indicated poly(I:C)-primed mice were incubated for 6 h with B16 cells. Expression of CD107a on NK cells (NK1.1+CD3−; G) or DNAM1+ NK cells (NK1.1+CD3−DNAM-1+; H) was analyzed by flow cytometry. Splenocytes alone or splenocytes stimulated with phorbol myristate acetate and
ionomycin (PMA/iono) served as controls. Representative dot plots are shown in (G, left). Percentages of CD107a-positive NK cells are shown above the
blue boxes. Average values with SDs of triplicate values from one representative experiment are depicted in G (right; H). Unpaired Student’s t tests were
performed. ***, P < 0.001. Representative of n = 4 (G and H).
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DNAM-1 in pull-down assays. Third, mutation of Y319 or
N321 eliminated the ability of DNAM-1 to bind Grb2 and,
in parallel, abolished its capacity to signal and enhance cytotoxicity in a system in which cytotoxicity was strictly dependent on DNAM-1. Fourth, depletion of Grb2 using two
different siRNAs reduced the ability of DNAM-1 to mediate
killing by YT-S cells, once again in a setting where killing
was absolutely DNAM-1 dependent. Fifth, other effectors of
DNAM-1 signaling, namely Vav-1, c-Cbl, SHIP-1, and p85
of PI3′K are known to bind the SH3 domains of Grb2
(Ramos-Morales et al., 1994; Odai et al., 1995; Wang et al.,
1995; Kavanaugh et al., 1996).
Although the role of these various effectors in DNAM-1–
mediated signals and cytotoxicity remains to be clarified, we
speculate that Vav-1, PI3′K, and PLC-γ1 were likely responsible for DNAM-1–elicited activation of Erk, Akt, and calcium fluxes, as well as for induction of effector functions. Our
experiments with pharmacological inhibitors suggested that
PI3′K and, to a lesser extent, calcium fluxes were especially
important for induction of cytotoxicity. Conversely, c-Cbl
and SHIP-1 might be part of a negative feedback mechanism
aimed at restricting the activating impact of DNAM-1.
Early studies showed that human DNAM-1 promoted
adhesion between NK cells and target cells (Shibuya et al.,
1996). This finding was confirmed in the present study using
mouse DNAM-1. However, we also observed that, although
the signal-defective DNAM-1 mutants Y319F and N321Q
promoted conjugate formation, they failed to enhance cytotoxicity. This observation implied that enhanced adhesion was not
sufficient for the activating function of DNAM-1. Along these
lines, confocal microscopy studies in YT-S cells showed that WT
DNAM-1 was also able to augment actin polymerization and
polarization of lytic granules toward target cells. Importantly,
these effects were absent with the signal-defective Y319F and
N321Q DNAM-1 variants. The ability of DNAM-1 to promote granule exocytosis was also eliminated when the Y319F
mutation was introduced in mouse NK cells. On these bases, we
propose that DNAM-1–induced adhesion is likely to be important, but is not sufficient, for enhancing NK cell activation.
In addition, the ability of DNAM-1, at least mouse DNAM-1, to
stimulate actin polymerization and granule polarization, which
require DNAM-1 signaling, is required. Although it remains to
be established that an analogous mechanism exists for human
DNAM-1, it seems likely to be the case as the signaling motif of
DNAM-1 is strictly conserved in human DNAM-1.
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MATERIALS AND METHODS
Mice.To generate a mouse strain in which Y319 of DNAM-1
was substituted by phenylalanine, the targeting vector depicted in Fig. 3 A was created. This construct contained a
JEM Vol. 212, No. 12

5-kb 3′ arm harboring exon 7, in which the codon for Y319
(TAT) was replaced by the codon for phenylalanine (TTT).
The construct was transfected in C57BL/6-derived Bruce 4
ES cells. Cells with successful homologous recombination
were injected into blastocysts to generate chimeric mice.
After germline transmission, mice were crossed with a transgenic mouse expressing the Flpe recombinase [B6.SJLFLPe)9205Dym/J; The Jackson Laboratory] to
Tg(ACT
eliminate the neo cassette. Presence of the DNAM-1 Y319F
mutation was confirmed by sequencing of mouse genomic
DNA. DNAM-1–deficient mice in the C57BL/6 background were previously described (Gilfillan et al., 2008).
LFA-1–deficient mice (B6.129S7-Itgaltm1Bll/J) were obtained
from The Jackson Laboratory (Ding et al., 1999). Mice lacking Fyn were described previously (Dong et al., 2012). All
mice were maintained in the C57BL/6 background. Littermates were used as controls in all experiments. Animal experimentation was approved by the Animal Care Committee
of IRCM and performed as defined by the Canadian
Council of Animal Care.
cDNAs, plasmids, and siRNAs.cDNAs encoding mouse
DNAM-1 and CD155 were obtained from Thermo Fisher
Scientific. Mutants of DNAM-1 (Y319F; S326A; N321Q;
Y322F) were generated by PCR using the Site-Directed
Mutagenesis Kit (QuickChange; Agilent Technologies), according to the instructions of the manufacturer. The resulting
cDNAs were verified by sequencing (unpublished data). For
expression in YT-S cells, cDNAs coding for DNAM-1 were
cloned into the vector pSRα-Puro, which contains the puromycin resistance gene (puro). For expression in Cos-1 cells,
cDNAs encoding DNAM-1 or various PTKs were cloned in
the vector pXM139. For expression of CD155 in RMA-S
cells, the cDNA encoding CD155 was cloned into the retroviral vector pFB-GFP. Grb2-specific siRNAs (SI00300328,
SI02654750) and control scrambled siRNAs (1027280) were
obtained from QIAGEN. Transfection of siRNAs into YT-S
cells was performed as described elsewhere (Guo et al., 2015).
Cells.To obtain freshly isolated NK cells, mice were injected
intraperitoneally with poly(I:C; 250 µg; Sigma-Aldrich). After
36 h, spleen NK cells were purified by positive selection (STE
MCELL Technologies). For generation of IL-2–activated NK
cells, spleen NK cells were enriched by negative selection
(STEMCELL Technologies) and cultured for 5 d in the presence of 1,000 U/ml of mouse IL-2 (PeproTech).YT-S (human
NK cell line), B16F10 (mouse melanoma), CMT-93 (mouse
rectal carcinoma), RMA-S (mouse lymphoma), and YAC-1
(mouse thymoma) were described (Dong et al., 2009;
Pérez-Quintero et al., 2014). Neuro-2a (neuroblastoma) was
a gift from N. Seidah (Institut de recherches cliniques de
Montréal, Montreal, Quebec, Canada). YT-S cells expressing
various mutants of mouse DNAM-1 were generated by electroporation and selected in puromycin-containing medium.
RMA-S cells expressing green fluorescent protein (GFP)
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adaptor DAP-10 (Engels and Wienands, 2011). Conversely,
CD28 interacts with Grb2 through the sequence pYMNM,
whereas membrane-bound IgG binds Grb2 via the sequence
pYRNM. In this manner, DNAM-1 is analogous to ITT motif-bearing receptors. However, in the case of NKG2D, CD28,
and surface IgG, the ITT motif also directly interacts with the
p85 subunit of PI3′K. This interaction is dependent on the
methionine at the +3 position of their ITT motif. Although
DNAM-1 does not carry a methionine at the +3 position, it
also coupled to PI3′K, seemingly by an indirect mechanism
involving binding of Grb2 to p85. Thus, it would appear that
DNAM-1 also signals via an ITT-like motif.
One of the concerns in elucidating the functions of
DNAM-1 using DNAM-1–deficient mice is that loss of
DNAM-1 not only obliterates DNAM-1–dependent signals,
but also frees DNAM-1 ligands for potential binding to inhibitory receptors TIGIT and CD96 (Martinet and Smyth,
2015). Thus, enhanced triggering of TIG
IT and CD96,
rather than loss of DNAM-1–dependent signals, might explain functional changes in DNAM-1–deficient immune
cells. Our finding that mutation of Y319 of DNAM-1 markedly reduced DNAM-1–dependent cytotoxicity and cytokine production in mouse NK cells, without compromising
DNAM-1 expression, firmly established that these functions
are intrinsic activities of DNAM-1. Given the functional interplay between DNAM-1, CD96, and TIGIT in anti-tumor
immunity in vivo, it will be interesting in the future to examine if tumor rejection and mouse survival differs between
animals lacking DNAM-1 (in which DNAM-1 function is
ablated, and DNAM-1 ligands are more available for CD96
and TIGIT) and mice expressing DNAM-1 Y319F (in which
DNAM-1 signaling is compromised, but DNAM-1 ligands
are presumably not more available for CD96 and TIGIT).
In summary, our results showed that DNAM-1 mediates
active biochemical signals that are essential for its capacity
to enhance NK cell cytotoxicity and cytokine production.
These signals are initiated by a conserved ITT or ITT-like
motif (pYxNx), which undergoes phosphorylation by Src
family kinases and recruits the adaptor Grb2. In turn, Grb2
activates Vav-1, PI3′K, and PLC-γ1, which leads to activation of Erk, Akt, and calcium fluxes. Such a pathway promotes actin polymerization and granule polarization, thereby
enhancing cytotoxicity. As DNAM-1 is expressed in other
immune cells, including CD8+ T cells, it is reasonable to speculate that DNAM-1 mediates similar signals and effects in
these cells. Likewise, it is likely that an enhancement of these
signals, due to augmented triggering of DNAM-1 by its ligands, underlies the therapeutic impact of blocking anti-TIG
IT antibodies for treatment of cancer and viral infections
(Johnston et al., 2014).
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alone or in combination with mouse CD155 were produced
by retroviral infection, as detailed previously (Cruz-Munoz et
al., 2009). Cos-1 (monkey kidney fibroblast) and its transfection were outlined previously (Guo et al., 2015).

In vitro NK cell assays.51Cr release assays were performed as
outlined previously, using either YT-S cells or IL-2–activated
NK cells (Dong et al., 2009). For measurement of IFN-γ production and CD107a exposure, splenocytes (1 × 106) from
poly(I:C)-primed mice were incubated for 6 h with B16 cells
(1 × 105), and assays were performed as previously described
(Dong et al., 2009). Splenocytes stimulated with phorbol
myristate acetate (50 ng/ml) plus ionomycin (1 µM) served as
controls. For inhibition of PI3′K and the upstream activator
of Erk, MEK,YT-S cells, or splenocytes were preincubated for
1 h with 0.1 µM wortmannin (EMD Millipore) or 1 µM
U0126 (Sigma-Aldrich), respectively. For inhibition of calcium fluxes, YT-S cells were preincubated for 0.5 h with
40 µM BAPTA-AM (Sigma-Aldrich). For inhibition of Btk,
YT-S cells were preincubated for 0.5 h with 10 nM ibrutinib
(Sigma-Aldrich). For immunoblot analyses, YT-S cells or
IL-2–activated mouse NK cells were incubated with anti–
mouse DNAM-1 (480.2) for 10 min at room temperature.
After being washed, cells were stimulated with the relevant
2180

Peptide pull-down assay, silver staining, and mass spectrometry.Biotinylated peptides encompassing the 19 aa C-terminal
sequence of mouse DNAM-1, phosphorylated or not at
Y319, were synthesized by the W.M. Keck Facility (Yale University). Variants of this peptide in which individual residues
were mutated were also created. Peptide pull-down assay was
performed as described previously (Dong et al., 2009;
Pérez-Quintero et al., 2014). Silver staining and mass spectrometry were performed at the Proteomic Mass Spectrometry Platform of IRCM.
Statistical analyses.Prism 6 (GraphPad Software) was used
for unpaired Student’s t tests (two-tailed).
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